These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3184196)

  • 1. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease.
    Pavlovsky S; Maschio M; Santarelli MT; Muriel FS; Corrado C; Garcia I; Schwartz L; Montero C; Sanahuja FL; Magnasco O
    J Natl Cancer Inst; 1988 Nov; 80(18):1466-73. PubMed ID: 3184196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
    Pavlovsky S; Schvartzman E; Lastiri F; Magnasco H; Corrado C; Raslawski E; Cancela ME; Ardaiz MC; Cerutti I; Rosso A; Bruno S; Aranguren PN; Salvarezza A; Donato H; Dibar E; Zirone S
    J Clin Oncol; 1997 Jul; 15(7):2652-8. PubMed ID: 9215837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
    Pavlovsky S; Santarelli MT; Muriel FS; Fernández I; Garcia I; Schwartz L; Montero C; Sanahuja FL; Magnasco H; Costa A
    Ann Oncol; 1992 Jul; 3(7):533-7. PubMed ID: 1498073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
    Sackmann-Muriel F; Zubizarreta P; Gallo G; Scopinaro M; Alderete D; Alfaro E; Casak S; Chantada G; Felice MS; Quinteros R
    Med Pediatr Oncol; 1997 Dec; 29(6):544-52. PubMed ID: 9324342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
    Vinciguerra V; Propert KJ; Coleman M; Anderson JR; Stutzman L; Pajak TF; Nissen NI; Frizzera G; Gottlieb A; Holland JF
    J Clin Oncol; 1986 Jun; 4(6):838-46. PubMed ID: 2423652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH; Wiernik PH; Levi JA; Kvols LK
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.
    Coleman M; Rafla S; Propert KJ; Glicksman A; Peterson B; Nissen N; Brunner K; Holland JF; Anderson JR; Gottlieb A; Kaufman T
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):639-45. PubMed ID: 9635714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the prognosis of adult Hodgkin's lymphoma in the past 35 years through clinical trials in Argentina: a GATLA experience.
    Pavlovsky S; Lastiri F
    Clin Lymphoma; 2004 Sep; 5(2):102-9. PubMed ID: 15453925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
    Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.
    Morgenfeld M; Somoza N; Magnasco J; Pavlovsky S; de Bonesana AC; Bezares R; Suárez A; Pileggi J; Lein JM; Macchi A; Calabria SI; Garay GE; de Sica SC; Besuschio S
    Cancer; 1979 May; 43(5):1579-86. PubMed ID: 376095
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
    Gabryś K; Urbaniak-Kujda D; Dubowik R
    Pol Arch Med Wewn; 1996 Nov; 96(5):469-73. PubMed ID: 9091857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
    Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease in childhood: therapy results in Argentina.
    Sackmann-Muriel F; Bonesana AC; Pavlovsky S; Papendieck C; Morgenfeld M; Penchansky L; Schwartz L; Kvicala R; Sica M; Ojeda F
    Am J Pediatr Hematol Oncol; 1981; 3(3):247-54. PubMed ID: 7025683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
    Cramer P; Andrieu JM
    J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.